Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Five Maternal Deaths in Kota Linked to Faulty Oxytocin Vials from Punjab Manufacturer

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Five Maternal Deaths in Kota Linked to Faulty Oxytocin Vials from Punjab Manufacturer

Analysed 5 Jul 2026·2 sources analysed·Kota, Rajasthan, India·Business
Five Maternal Deaths in Kota Linked to Faulty Oxytocin Vials from Punjab ManufacturerPreviousNext

Five young mothers in Kota died within days after receiving oxytocin injections that were later found to contain only water. Investigations revealed that the Punjab-based manufacturer, Jackson Laboratories, had fabricated test data, tampered with equipment, and ignored stop-production orders issued three years prior. This incident highlights significant regulatory failures in drug safety and raises concerns about patient protection in India’s healthcare system.

TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. Coverage leans left-leaning overall (Left 70%, Centre 25%, Right 5%). Overall sentiment is negative (25/100). Lens Score 62/100 — moderate public interest.

Outlets analysed (first-hand measurement by TBN's Bias Engine):

  • economictimes— left-leaning framing, negative sentiment
  • economictimes— left-leaning framing, negative sentiment
Political Bias
70%25%5%
Sentiment
25%
AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 5 Jul 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 2 sources
● Left 70%● Center 25%● Right 5%

The articles primarily focus on systemic healthcare and regulatory issues without partisan framing. They highlight failures in drug regulation and oversight, emphasizing the manufacturer's misconduct and regulatory lapses. The coverage includes perspectives of affected families and official investigations, presenting a critical but factual account without aligning with specific political ideologies.

Sentiment — Negative (25/100)

The overall tone is somber and critical, reflecting the tragic loss of life and the serious implications of regulatory negligence. While the articles convey empathy for the victims and their families, the sentiment is predominantly negative due to the exposure of malpractice and systemic failures in healthcare safety.

How 2 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

Reviewed byMrunal Wange· Business & Economy Editor· Edited byOjas Kale
← Previous
AI Tools Support Rapid Growth of Mental Health Startup Amid Economic Review
Next →
Prime Minister Modi Inaugurates Rs 740-Crore Karwar-Dangiyawas Section of Jodhpur Ring Road
SourceTheir headlineBiasSentiment
economictimeseconomic times: The Water in the VialLeftNegative
economictimesDeath in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareLeftNegative

Coverage timeline

economictimes broke this story on 5 Jul, 02:56 am. Other outlets followed.

  1. 1
    economictimes5 Jul, 02:56 am
    Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcare
  2. 2
    economictimes5 Jul, 09:30 am
    economic times: The Water in the Vial

Lens Score breakdown

62/100
Public interest32/100
Coverage gap100%

Moderately important story that could benefit from broader coverage.

Accountability flags

TBN's analysis identified the following accountability dimensions in this story.

  • financial irregularity

    This story involves alleged financial misconduct — unexplained transactions, procurement irregularities, or misuse of public/shareholder funds.

  • systemic failure

    This story points to a failure in institutional processes — regulation, safety, oversight, or service delivery breaking down at scale.

  • cover up attempted

    This story involves evidence of information being withheld, records altered, or facts suppressed by the parties involved.

  • public safety issue

    This story involves a risk to public safety — infrastructure failure, regulatory lapse, hazardous conditions, or emergency mishandling.

Who's involved

Institutions and figures named across source coverage.

Government
Central Drugs Standard Control OrganisationRajasthan authoritiesPunjab Food and Drugs AdministrationRajasthan Food Safety and Drug Control Commissionerate
Corporate
Punjab ManufacturerJackson LaboratoriesHemmo Pharmaceuticals

Story context

Category
Business
Location
Kota, Rajasthan, India
Sources analysed
2
Last analysed
5 Jul 2026
Key entities
OxytocinChildbirthBleedingCentral Drugs Standard Control OrganisationQuality controlCaesarean sectionActive ingredientFood and Drug AdministrationKota, RajasthanPunjab, IndiaRajasthanIndia